196 related articles for article (PubMed ID: 30261271)
1. Antimicrobial susceptibility and molecular typing of toxigenic clinical isolates of Clostridium difficile causing infections in the south of Spain.
Arca-Suárez J; Galán-Sánchez F; Cano-Cano F; García-Santos G; Rodríguez-Iglesias MA
Anaerobe; 2018 Dec; 54():146-150. PubMed ID: 30261271
[TBL] [Abstract][Full Text] [Related]
2. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
Nyc O; Tejkalova R; Kriz Z; Ruzicka F; Kubicek L; Matejkova J; Kuijper E; Krutova M
Microb Drug Resist; 2017 Jul; 23(5):609-615. PubMed ID: 27860531
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
Lachowicz D; Pituch H; Obuch-Woszczatyński P
Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
[TBL] [Abstract][Full Text] [Related]
4. A nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea.
Byun JH; Kim H; Kim JL; Kim D; Jeong SH; Shin JH; Kim YA; Shin JH; Shin KS; Uh Y
Anaerobe; 2019 Dec; 60():102106. PubMed ID: 31655214
[TBL] [Abstract][Full Text] [Related]
5. The recognition and characterisation of Finnish Clostridium difficile isolates resembling PCR-ribotype 027.
Krutova M; Nyc O; Matejkova J; Kuijper EJ; Jalava J; Mentula S
J Microbiol Immunol Infect; 2018 Jun; 51(3):344-351. PubMed ID: 28583353
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiology and resistance profiles of Clostridium difficile in a tertiary care hospital in Spain.
Weber I; Riera E; Déniz C; Pérez JL; Oliver A; Mena A
Int J Med Microbiol; 2013 Apr; 303(3):128-33. PubMed ID: 23523477
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains.
Huang H; Weintraub A; Fang H; Wu S; Zhang Y; Nord CE
Anaerobe; 2010 Dec; 16(6):633-5. PubMed ID: 20849968
[TBL] [Abstract][Full Text] [Related]
8. High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
Cheng JW; Yang QW; Xiao M; Yu SY; Zhou ML; Kudinha T; Kong F; Liao JW; Xu YC
J Microbiol Immunol Infect; 2018 Jun; 51(3):411-416. PubMed ID: 28693926
[TBL] [Abstract][Full Text] [Related]
9. Changes in Clostridium (Clostridioides) difficile PCR-Ribotype Distribution and Antimicrobial Resistance in a German Tertiary Care Hospital Over the Last 10 Years.
Piepenbrock E; Stelzer Y; Berger F; Jazmati N
Curr Microbiol; 2019 Apr; 76(4):520-526. PubMed ID: 30805700
[TBL] [Abstract][Full Text] [Related]
10. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH;
Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
[TBL] [Abstract][Full Text] [Related]
11. Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea.
Kim J; Kang JO; Pai H; Choi TY
Int J Antimicrob Agents; 2012 Jul; 40(1):24-9. PubMed ID: 22578765
[TBL] [Abstract][Full Text] [Related]
12. The characteristics of Clostridium difficile ST81, a new PCR ribotype of toxin A- B+ strain with high-level fluoroquinolones resistance and higher sporulation ability than ST37/PCR ribotype 017.
Wang B; Peng W; Zhang P; Su J
FEMS Microbiol Lett; 2018 Sep; 365(17):. PubMed ID: 30085003
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of Clostridium difficile isolates from ICU colonized patients revealed alert to ST-37 (RT 017) isolates.
Yang J; Zhang X; Liu X; Cai L; Feng P; Wang X; Zong Z
Diagn Microbiol Infect Dis; 2017 Oct; 89(2):161-163. PubMed ID: 28800896
[TBL] [Abstract][Full Text] [Related]
14. Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
López-Ureña D; Quesada-Gómez C; Montoya-Ramírez M; del Mar Gamboa-Coronado M; Somogyi T; Rodríguez C; Rodríguez-Cavallini E
Emerg Microbes Infect; 2016 May; 5(5):e42. PubMed ID: 27165560
[TBL] [Abstract][Full Text] [Related]
15. The emergence of Clostridium difficile PCR ribotype 078 in piglets in the Czech Republic clusters with Clostridium difficile PCR ribotype 078 isolates from Germany, Japan and Taiwan.
Krutova M; Zouharova M; Matejkova J; Tkadlec J; Krejčí J; Faldyna M; Nyc O; Bernardy J
Int J Med Microbiol; 2018 Oct; 308(7):770-775. PubMed ID: 29859665
[TBL] [Abstract][Full Text] [Related]
16. Molecular characteristics of Clostridium difficile strains from patients with a first recurrence more than 8 weeks after the primary infection.
Chen Y; Rashid MU; Huang H; Fang H; Nord CE; Wang M; Weintraub A
J Microbiol Immunol Infect; 2017 Aug; 50(4):532-536. PubMed ID: 26698688
[TBL] [Abstract][Full Text] [Related]
17. PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates.
Solomon K; Fanning S; McDermott S; Murray S; Scott L; Martin A; Skally M; Burns K; Kuijper E; Fitzpatrick F; Fenelon L; Kyne L
J Antimicrob Chemother; 2011 Sep; 66(9):1976-82. PubMed ID: 21712239
[TBL] [Abstract][Full Text] [Related]
18. Clostridium difficile ribotype 176 - A predictor for high mortality and risk of nosocomial spread?
Polivkova S; Krutova M; Petrlova K; Benes J; Nyc O
Anaerobe; 2016 Aug; 40():35-40. PubMed ID: 27155489
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from a university teaching hospital in Japan.
Kuwata Y; Tanimoto S; Sawabe E; Shima M; Takahashi Y; Ushizawa H; Fujie T; Koike R; Tojo N; Kubota T; Saito R
Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):763-72. PubMed ID: 25471195
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile isolated from faecal samples in patients with ulcerative colitis.
Shoaei P; Shojaei H; Jalali M; Khorvash F; Hosseini SM; Ataei B; Vakili B; Ebrahimi F; Tavakoli H; Esfandiari Z; Weese JS
BMC Infect Dis; 2019 Apr; 19(1):361. PubMed ID: 31039738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
